The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers

BACKGROUND: Limited data exist on the real‐world costs of applying whole‐genome analysis (WGA) in a clinical setting. We estimated the costs of applying WGA to guide treatments for patients with advanced cancers and characterized how costs evolve over time. METHODS: The setting is the British Columb...

Descripción completa

Detalles Bibliográficos
Autores principales: Weymann, Deirdre, Laskin, Janessa, Roscoe, Robyn, Schrader, Kasmintan A., Chia, Stephen, Yip, Stephen, Cheung, Winson Y., Gelmon, Karen A., Karsan, Aly, Renouf, Daniel J., Marra, Marco, Regier, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441418/
https://www.ncbi.nlm.nih.gov/pubmed/28546995
http://dx.doi.org/10.1002/mgg3.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441418/
https://www.ncbi.nlm.nih.gov/pubmed/28546995
http://dx.doi.org/10.1002/mgg3.281

Ejemplares similares